Literature DB >> 11231928

Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study.

P Lind1, B Hedblad, L Stavenow, L Janzon, K F Eriksson, F Lindgärde.   

Abstract

Inflammation may play an important role in atherosclerotic disease. Plasma fibrinogen is an established predictor of cardiovascular events. The aim of this study was to evaluate whether other inflammation-sensitive plasma proteins modify this prediction. We studied the incidence of cardiac events and death in men in relation to fibrinogen levels alone and in combination with other proteins. The study was based on 6075 men, who were, on average, 46 years old at the time of the screening examination, which included the quantitative assessment of plasma levels of fibrinogen, orosomucoid, alpha(1)-antitrypsin, haptoglobin, and ceruloplasmin. The concentration of each protein was divided into quartiles for each. This classification made it possible to identify 4 groups, ie, men in the first fibrinogen quartile and at the same time either not belonging to the fourth quartile of any of the other proteins (Q1/No group) or also belonging to the fourth quartile of >/=1 of the additional proteins (Q1/Yes group) and corresponding groups in the fourth fibrinogen quartile (Q4/No and Q4/Yes groups). During the follow-up, which occurred at an average of 16 years, 439 (7.2%) men experienced a cardiac event, and 653 (10.7%) died; 278 of these men died of cardiovascular diseases, with 206 deaths attributed to ischemic heart disease. From the lowest to the highest quartile, there was for each protein a stepwise increase in the incidence of cardiac events and mortality. All-cause mortality and cardiovascular mortality were significantly higher in the Q4/Yes group compared with the Q4/No group, but they were similar in the Q4/No and Q1/Yes groups. The incidence of cardiac events was significantly higher in the Q1/Yes and Q4/Yes groups compared with the Q1/No and Q4/No groups, respectively. The increased cardiovascular mortality and cardiac event rates remained after adjustment for several confounders when the Q4/Yes and Q4/No groups were compared. The results suggest that the incidence of cardiac events and death due to cardiovascular diseases in middle-aged men predicted by plasma levels of fibrinogen is modified by other inflammation-sensitive proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231928     DOI: 10.1161/01.atv.21.3.452

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  Ceruloplasmin (ferroxidase) oxidizes hydroxylamine probes: deceptive implications for free radical detection.

Authors:  Douglas Ganini; Donatella Canistro; JinJie Jiang; JinJie Jang; Krisztian Stadler; Ronald P Mason; Maria B Kadiiska
Journal:  Free Radic Biol Med       Date:  2012-07-21       Impact factor: 7.376

2.  Short term changes in lung function, leukocytosis in blood, and lachrymal fluid among bacterial single cell protein workers after an episode with high exposure to endotoxins.

Authors:  M Skogstad; W Eduard; J Holme; T Qvenild; E Einarsdottir
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

Review 3.  Personalized protein corona on nanoparticles and its clinical implications.

Authors:  Claudia Corbo; Roberto Molinaro; Mateen Tabatabaei; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

4.  Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

Authors:  B Balkau; G Hu; Q Qiao; J Tuomilehto; K Borch-Johnsen; K Pyörälä
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

5.  Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women.

Authors:  N Tajik; A Golpaie; S A Keshavarz; M Djalali; M Sehat; F Masoudkabir; Z Ahmadivand; F Fatehi; M Zare; T Yazdani
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

6.  Biomarkers of Human Cardiopulmonary Response After Short-Term Exposures to Medical Laser-Generated Particulate Matter From Simulated Procedures: A Pilot Study.

Authors:  Ramon Lopez; Mark O Farber; Vincent Wong; Steven E Lacey
Journal:  J Occup Environ Med       Date:  2016-09       Impact factor: 2.162

7.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

8.  Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction.

Authors:  Natale Daniele Brunetti; Pier Luigi Pellegrino; Michele Correale; Luisa De Gennaro; Andrea Cuculo; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

9.  Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes.

Authors:  M K Heliövaara; M Herz; A-M Teppo; E Leinonen; P Ebeling
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

10.  Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: a case control study.

Authors:  Mohammad Shojaie; Morteza Pourahmad; Ahad Eshraghian; Hamid Reza Izadi; Farzan Naghshvar
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.